ClinicalTrialsFinder

Castration Sensitive Prostate Cancer Clinical Trials in Ottawa, Ontario

1 recruitingOttawa, Ontario, Canada

Showing 1–1 of 1 trials

Recruiting
Phase 2

Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC)

Prostate AdenocarcinomaCastration Sensitive Prostate Cancer
Ontario Clinical Oncology Group (OCOG)162 enrolled3 locationsNCT06654336